WALTHAM, Mass., March 18 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. announced today that it will host a conference call and Webcast on Thursday, March 25, 2010 at 4:30 p.m. ET to discuss the Company’s fourth quarter and year end 2009 financial results.
About Interleukin Genetics, Inc.
Interleukin Genetics, Inc. develops and markets genetic tests that empower consumers to prevent chronic diseases and that assist pharmaceutical companies in the development and marketing of targeted therapeutics. The Company leverages its research, intellectual property and biomarker development experience to facilitate the emerging personalized health market. Interleukin Genetics markets a line of genetic tests under the Inherent Health brand including Bone Health, Weight Management, Heart Health and Nutritional Needs. The Company is headquartered in Waltham, MA. For more information please visit http://www.ilgenetics.com.
CONTACT: Erin Walsh, Interleukin Genetics, Inc., +1-781-419-4707,
ewalsh@ilgenetics.com
Web site: http://www.ilgenetics.com/
